ERBA Diagnostics, Inc. Appoints Hayden Jeffreys as Interim Chief Executive Officer
29 nov. 2016 16h30 HE
|
ERBA Diagnostics, Inc.
MIAMI, Nov. 29, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (OTC PINK:ERBA) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, effective as of January 1,...
ERBA Diagnostics to Commence Trading on OTC Markets’ Pink Open Market After Delisting by the NYSE MKT
30 sept. 2016 16h00 HE
|
ERBA Diagnostics, Inc.
MIAMI, Sept. 30, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (the “Company”), a fully integrated in vitro diagnostics company, previously disclosed that the Company expected the NYSE MKT LLC...
ERBA Diagnostics, Inc. Announces Inability to Meet Deadline to Regain Compliance With NYSE MKT Continued Listing Standards
29 sept. 2016 16h05 HE
|
ERBA Diagnostics, Inc.
MIAMI, Sept. 29, 2016 (GLOBE NEWSWIRE) -- As previously reported, ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, implemented during the third...
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards
26 août 2016 16h15 HE
|
ERBA Diagnostics, Inc.
MIAMI, Aug. 26, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, on August 23, 2016, the Company...
ERBA Diagnostics, Inc. Announces Extension of CEO’S Contract Term and Appointment of Hayden Jeffreys to Board of Directors
31 mai 2016 16h15 HE
|
ERBA Diagnostics, Inc.
MIAMI, May 31, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that it has entered into an amendment...
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan
20 mai 2016 16h15 HE
|
ERBA Diagnostics, Inc.
MIAMI, May 20, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, on May 19, 2016, the Company...
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards
21 avr. 2016 16h45 HE
|
ERBA Diagnostics, Inc.
MIAMI, April 21, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that, on April 15, 2016, the Company...
ERBA Diagnostics’ Compliance Plan Accepted by NYSE MKT
27 janv. 2016 08h00 HE
|
ERBA Diagnostics, Inc.
MIAMI, Jan. 27, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, announced today that the Company received a letter...
ERBA Diagnostics, Inc. Announces the Consummation of the Capital Infusion of $3.5 Million Into the Company
29 déc. 2015 08h05 HE
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., Dec. 29, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the “Company”), a fully integrated in vitro diagnostics company, has consummated the capital infusion of...
ERBA Diagnostics Inc. Annual General Meeting CEO’s Speech on the Company’s Progress in 2015
17 déc. 2015 08h00 HE
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., Dec. 17, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) At ERBA Diagnostics, Inc.’s annual meeting of stockholders held on December 15, 2015, Mohan Gopalkrishnan,...